Results 151 to 160 of about 37,814 (299)

A Review of Ranibizumab for the Treatment of Diabetic Retinopathy

open access: yesOphthalmology and Therapy, 2017
Laser photocoagulation has been the standard treatment for diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) for several decades. The discovery of vascular endothelial growth factor (VEGF) and the subsequent determination of its critical role in the development DME and PDR has led to the development of VEGF inhibitory drugs ...
openaire   +2 more sources

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Implication of VEGF as a Critical Stimulator [PDF]

open access: hybrid, 2008
Peter A. Campochiaro   +15 more
openalex   +1 more source

Antibody Engineering to Enhancement of Ranibizumab Binding Affinity for the Prevention and Treatment of Diabetic Retinopathy [PDF]

open access: yesIranian Journal of Diabetes and Obesity
Objective: The VEGF function blockage effectively reduces the progression of diabetic retinopathy. Ranibizumab and bevacizumab are some anti-VEGF monoclonal antibodies (mAb).
Fateme Sefid   +3 more
doaj  

Intravitreal ranibizumab (Lucentis®) for the treatment of myopic choroidal neovascularization [PDF]

open access: green, 2008
Lazaros Konstantinidis   +4 more
openalex   +1 more source

The intravitreal injection: Variations in regulations, cost and reimbursement in Europe [PDF]

open access: yes, 2018
Zusammenfassung: HINTERGRUND: Grosse prospektive, randomisierte, kontrollierte klinische Studien haben für den intravitrealen Einsatz von Inhibitoren des vaskulären endothelialen Wachstumsfaktors (VEGF) klare Behandlungsvorgaben mit höchstem ...
Becker, M.   +3 more
core  

Home - About - Disclaimer - Privacy